Scarica l'app Stockscreener
1.305
1.16%
0.015
Precedente Chiudi:
$1.29
Aprire:
$1.29
Volume 24 ore:
1.28M
Relative Volume:
0.70
Capitalizzazione di mercato:
$495.67M
Reddito:
$106.34M
Utile/perdita netta:
$-74.66M
Rapporto P/E:
-1.3737
EPS:
-0.95
Flusso di cassa netto:
$-46.12M
1 W Prestazione:
+0.38%
1M Prestazione:
+0.38%
6M Prestazione:
-5.43%
1 anno Prestazione:
-21.86%
Intervallo 1D:
$1.29
$1.325
Intervallo di 1 settimana:
$1.27
$1.365
Portata 52W:
$0.92
$2.32
Standard Biotools Inc Stock (LAB) Company Profile
Nome
Standard Biotools Inc
Settore
Industria
Telefono
(650) 266-6000
Indirizzo
2 TOWER PLACE, SOUTH SAN FRANCISCO
Confronta LAB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.305 | 462.39M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-27 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Iniziato | TD Cowen | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-12 | Iniziato | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Borsa (LAB) Ultime notizie
Standard BioTools LAB Q2 2025 Earnings Preview Upside Potential on Strategic Expansion - AInvest
Standard BioTools Q2 2025 Earnings Preview - MSN
Standard BioTools Q2 2025 Earnings Outlook: Strategic Shifts, Revenue Pressures, and the Path to Value Creation - AInvest
What to Expect from Standard BioTools Inc (LAB) Q2 2025 Earnings - Yahoo Finance
Standard BioTools and Precision Health Research, Singapore - GlobeNewswire
Major Win: Standard BioTools Secures 100,000-Sample Singapore Biobank Deal for Population Health Study - Stock Titan
Why is Standard BioTools Inc. stock attracting strong analyst attentionUnlock daily stock market insights for success - Jammu Links News
How volatile is Standard BioTools Inc. stock compared to the marketInvest smarter with daily market updates - Jammu Links News
Is Standard BioTools Inc. a growth stock or a value stockBuild wealth with steady, reliable stocks - Jammu Links News
What analysts say about Standard BioTools Inc. stockInvest confidently with data-backed picks - Jammu Links News
How many analysts rate Standard BioTools Inc. as a “Buy”Maximize returns with effective portfolio management - Jammu Links News
What institutional investors are buying Standard BioTools Inc. stockDiscover stocks with explosive potential - Jammu Links News
What makes Standard BioTools Inc. stock price move sharplyMaximize your portfolio’s growth potential - Jammu Links News
Is Standard BioTools Inc. stock overvalued or undervaluedFree Popular Stock Recommendations - Jammu Links News
Is it the right time to buy Standard BioTools Inc. stockInvest smarter with expert stock recommendations - Jammu Links News
What catalysts could drive Standard BioTools Inc. stock higher in 2025Exceptional stock performance - Jammu Links News
What are Standard BioTools Inc. company’s key revenue driversUnlock hidden market opportunities today - Jammu Links News
What are the technical indicators suggesting about Standard BioTools Inc.Build wealth faster with consistent growth stocks - Jammu Links News
When is Standard BioTools Inc. stock expected to show significant growthUnlock expert insights for smarter investing - Jammu Links News
Standard BioTools Inc. Building a Base Near SupportConservative Entry for High Return Setup Backed - beatles.ru
Standard BioTools grants RSU awards to CEO and CFO, increases CFO bonus target - Investing.com Australia
Standard BioTools Approves Stock Awards for Executives - TipRanks
Illumina Beats Q2 Earnings Expectations, Boosts 2025 Outlook Despite Revenue Dip - Stock Titan
Trend analysis for Standard BioTools Inc. this weekFast Return Equity Trade Forecast Points to Small Caps - metal.it
Standard BioTools Inc. At Critical Juncture — Bounce or BreakdownTrade Scanner With Buy Zone Alerts Flagged - metal.it
Best data tools to analyze Standard BioTools Inc. stockAI Driven Stock Trend Forecast Shows Momentum Shift - metal.it
Reversal Traders Monitor Standard BioTools Inc. for EntryReal-Time Trade Insights Spark Market Reactions - metal.it
Standard BioTools Inc. Approaches Psychological Resistance LevelBeginner Friendly Stock Selection Guide Updated - metal.it
Order Book Volume Tilts Bullish on Standard BioTools Inc.Triple Digit Growth Focused Trade Plan Reviewed - metal.it
How does Standard BioTools Inc. generate profit in a changing economyUnlock exclusive stock analysis for investors - jammulinksnews.com
What are analysts’ price targets for Standard BioTools Inc. in the next 12 monthsFree Stock Data Feed Backed By Experts - Jammu Links News
Published on: 2025-07-27 17:18:15 - Jammu Links News
What drives Standard BioTools Inc. stock priceAccelerated wealth building - PrintWeekIndia
What institutions are buying Standard BioTools Inc. stock nowPhenomenal returns - Jammu Links News
Standard Biotools Inc Azioni (LAB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):